Best of the Week
Most Popular
1. Investing in a Bubble Mania Stock Market Trending Towards Financial Crisis 2.0 CRASH! - 9th Sep 21
2.Tech Stocks Bubble Valuations 2000 vs 2021 - 25th Sep 21
3.Stock Market FOMO Going into Crash Season - 8th Oct 21
4.Stock Market FOMO Hits September Brick Wall - Evergrande China's Lehman's Moment - 22nd Sep 21
5.Crypto Bubble BURSTS! BTC, ETH, XRP CRASH! NiceHash Seizes Funds on Account Halting ALL Withdrawals! - 19th May 21
6.How to Protect Your Self From a Stock Market CRASH / Bear Market? - 14th Oct 21
7.AI Stocks Portfolio Buying and Selling Levels Going Into Market Correction - 11th Oct 21
8.Why Silver Price Could Crash by 20%! - 5th Oct 21
9.Powell: Inflation Might Not Be Transitory, After All - 3rd Oct 21
10.Global Stock Markets Topped 60 Days Before the US Stocks Peaked - 23rd Sep 21
Last 7 days
Why Most Investors LOST Money by Investing in ARK FUNDS - 27th Jan 22
The “play-to-earn” trend taking the crypto world by storm - 27th Jan 22
Quantum AI Stocks Investing Priority - 26th Jan 22
Is Everyone Going To Be Right About This Stocks Bear Market?- 26th Jan 22
Stock Market Glass Half Empty or Half Full? - 26th Jan 22
Stock Market Quoted As Saying 'The Reports Of My Demise Are Greatly Exaggerated' - 26th Jan 22
The Synthetic Dividend Option To Generate Profits - 26th Jan 22
The Beginner's Guide to Credit Repair - 26th Jan 22
AI Tech Stocks State Going into the CRASH and Capitalising on the Metaverse - 25th Jan 22
Stock Market Relief Rally, Maybe? - 25th Jan 22
Why Gold’s Latest Rally Is Nothing to Get Excited About - 25th Jan 22
Gold Slides and Rebounds in 2022 - 25th Jan 22
Gold; a stellar picture - 25th Jan 22
CATHY WOOD ARK GARBAGE ARK Funds Heading for 90% STOCK CRASH! - 22nd Jan 22
Gold Is the Belle of the Ball. Will Its Dance Turn Bearish? - 22nd Jan 22
Best Neighborhoods to Buy Real Estate in San Diego - 22nd Jan 22
Stock Market January PANIC AI Tech Stocks Buying Opp - Trend Forecast 2022 - 21st Jan 21
How to Get Rich in the MetaVerse - 20th Jan 21
Should you Buy Payment Disruptor Stocks in 2022? - 20th Jan 21
2022 the Year of Smart devices, Electric Vehicles, and AI Startups - 20th Jan 21
Oil Markets More Animated by Geopolitics, Supply, and Demand - 20th Jan 21
WARNING - AI STOCK MARKET CRASH / BEAR SWITCH TRIGGERED! - 19th Jan 22
Fake It Till You Make It: Will Silver’s Motto Work on Gold? - 19th Jan 22
Crude Oil Smashing Stocks - 19th Jan 22
US Stagflation: The Global Risk of 2022 - 19th Jan 22
Stock Market Trend Forecast Early 2022 - Tech Growth Value Stocks Rotation - 18th Jan 22
Stock Market Sentiment Speaks: Are We Setting Up For A 'Mini-Crash'? - 18th Jan 22
Mobile Sports Betting is on a rise: Here’s why - 18th Jan 22
Exponential AI Stocks Mega-trend - 17th Jan 22
THE NEXT BITCOIN - 17th Jan 22
Gold Price Predictions for 2022 - 17th Jan 22
How Do Debt Relief Services Work To Reduce The Amount You Owe? - 17th Jan 22
RIVIAN IPO Illustrates We are in the Mother of all Stock Market Bubbles - 16th Jan 22
All Market Eyes on Copper - 16th Jan 22
The US Dollar Had a Slip-Up, but Gold Turned a Blind Eye to It - 16th Jan 22
A Stock Market Top for the Ages - 16th Jan 22
FREETRADE - Stock Investing Platform, the Good, Bad and Ugly Review, Free Shares, Cancelled Orders - 15th Jan 22
WD 14tb My Book External Drive Unboxing, Testing and Benchmark Performance Amazon Buy Review - 15th Jan 22
Toyland Ferris Wheel Birthday Fun at Gulliver's Rother Valley UK Theme Park 2022 - 15th Jan 22
What You Should Know About a TailoredPay High Risk Merchant Account - 15th Jan 22

Market Oracle FREE Newsletter

How to Protect your Wealth by Investing in AI Tech Stocks

Here’s How Pharma Is Using AI Deep Learning To Cure Aging

Companies / AI Mar 16, 2017 - 10:20 AM GMT

By: John_Mauldin

Companies

BY PATRICK COX : In 2011, scientists made one of the most important discoveries in the history of AI development. They found that graphics processing units (GPUs) are far better at simulating biological learning than central processing units (CPUs).

In retrospect, it seems obvious. Human brains are much more like GPUs than CPUs. Both brains and GPUs rely on parallel processing that simulates and predicts real world physics.


In light of this, AI developers created powerful deep neural networks (DNNs) that emulate human brain function. All the major advances in self-driving cars and language translation are the result of this.

Below is a chart from Nvidia. It shows the explosive progress of AI running the Caffe deep learning platform:

In the meantime, pharma is tapping into this breakthrough to cure the diseases of aging and cut healthcare costs.

Deep Learning and Aging

One company that took on aging is InSilico Medicine. InSilico is one of the biotech companies I write about in my weekly publication, Tech Digest (subscribe here for free). The company uses DNNs to sort through huge amounts of biological data. The DNNs look for biomarkers (measurable indicators of your biological state such as those included in blood tests) that correlate with aging. For humans, this would be an impossibly complicated and time-consuming task.

InSilico has developed a program that will guess your age within a few years based on a standard blood test. Why should you care?

The reason is that biomarkers indicating old age can be altered. We can identify compounds that can make your biomarkers—and you—younger and healthier. A few of these compounds are already known. But scientists lacked the technology to identify the most powerful ones... until now.

Today, there is a race to find the most effective and safest geroprotectors. These are compounds that can restore you and your biomarkers to a more youthful profile.

One player in this field is the Life Extension Foundation (LEF). It’s on a mission to find safe and effective natural geroprotectors without regulatory delays and costs.

Last week, InSilico Medicine announced a product called Ageless Cell. It was developed in collaboration with LEF’s head of R&D Andrew Swick, PhD, former Director of Cardiovascular and Metabolic Diseases at Pfizer Global Research and Development. The supplement contains four natural compounds that DNNs have shown can rejuvenate older cells.

LEF has access to blood tests from its customers who take the product. That means data should be available in less than a year. If it works, we can expect other DNN-developed geroprotectors.

Investment Implications

Many biotech companies, including startups, are using AI. That means investors can bet on this trend without exposure to the volatility of biotech startups.

Nvidia (NVDA) is the obvious way to play the growth of DNN applications. The company may have been overvalued at one point, but several negative reports drove its price back to bargain levels.

One indication of the potential of this company comes from Insilico Medicine’s CEO. He told me that the company ran calculations for the LEF supplement on a 40 Tflop 4xNvidia Titan X (Pascal architecture) supercomputer. Since then, Insilico built another GPU cluster using 16xTitan X (Pascal), delivering 160 Tflops in GPU computing power. 

Despite a collaborative relationship with Nvidia, Insilico couldn’t get all the Nvidia GPUs it needed for the project due to high demand for the processors. This points to strong growth potential in this market.

While Nvidia pioneered dedicated GPUs for AI, chip giant Intel (INTC) is catching up. Last year, Intel bought AI startup Nervana and integrated its deep learning architecture into Xeon microprocessors. Intel also benefits from an arrangement with Google to advance AI in multicloud environments.

One tech giant that doesn’t seem to be riding this wave is IBM. Big Blue made a big mistake by underestimating the market for AI computer components. Instead, IBM invested in its own cognitive system called Watson. IBM may expand its AI product line, but we’ll have to see if the shift comes in time to compete with Nvidia and Intel.

In any case, advanced AI is not just a marginal improvement in analytical tools. It’s the only technology capable of exploiting the massive knowledge gained from human genome sequencing.

Stay in the Loop on Life-Extending Research with Patrick Cox's Tech Digest

This weekly newsletter by biotech expert Patrick Cox highlights research that is much more advanced than most people know, and the profit potential for investors is vast. Read about the latest breakthroughs—from new, non-invasive cancer treatments to age-reversing nutraceuticals and vaccines that kill any virus–as well as the innovative companies that work on them. Get Tech Digest free in your inbox every Monday.

John Mauldin Archive

© 2005-2019 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in